ScreenerHero

CNTNCanton Strategic Holdings Inc. Common Stock

NAS · US · Healthcare · Biotechnology · cantonstrategic.com
2.190USD+4.78%Mkt Cap: 174.50M $P/E: —

Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-tech…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0
HeadlineSourceTime
Older
Tharimmune Investor Update Highlights Canton Network Growth, DTCC Pilot Momentum

Canton Strategic Holdings executives said the Canton Network saw higher transaction activity, broader institutional participation and significant governance changes during the second quarter, while highlighting a DTCC tokenization pilot and a growing market for Canton Coin locking services. Speakin

MarketBeat
Tharimmune Stockholders Elect Board, Ratify Auditor at 2026 Annual Meeting

Canton Strategic Holdings held its 2026 Annual Meeting of Stockholders virtually at 2:00 p.m. Eastern Time, with Chief Executive Officer and Chairman Mark Wendland presiding over the proceedings. Wendland said the meeting had been called by the company’s board of directors and that June 16, 2026, w

MarketBeat